Click Subscribe #StokeTherapeutics #Epilepsy #DravetSyndrome #Investing #Pharmaceuticals

Case builds for Biogen, Stoke's Dravet syndrome drug Hopes have risen for a new treatment for severe childhood epilepsy Dravet syndrome, on the back of new data for Biogen and Stoke's zorevunersen

#Biogen #Dravetsyndrome #childhoodepilepsy #StokeTherapeutics #zorevunersen #EMPERORtrial #antisenseoligonucleotide #ASO #SCN1Agenemutation #EPNS #Developmentalencephalopathy #epilepticencephalopathy #Dravetsyndromepatients #SUDEP #paediatricneurology
pharmaphorum.com/news/case-bu...

Lowered #FDA regulatory approval standards does not immediately translate to poorer #reimbursement prospects.

#biotechs already practice today to design trials to get adequate reimbursement when EMA approval standard too low for that. e.g. #StokeTherapeutics and Dravet's.